✳flâneur — a map of the web's best reading

Red Queen Bio

redqueen.bio · 214 words · saved by 1 readers

Today, we are launching Red Queen Bio, an AI biosecurity company. The Red Queen hypothesis describes a species’ co-evolution with ever-evolving opponents. As AI capabilities advance, biological risks grow exponentially. Our mission is to scale biological defenses at the same rate to ensure continuous human flourishing. We, the founders of Red Queen Bio (Nikolai and Hannu) have worked together for almost a decade as co-founders of HelixNano, a clinical-stage mRNA company. During a collaboration with OpenAI, we saw frontier models display remarkable biological creativity, with tremendous potential to help design breakthrough therapies. But in spite of our excitement, we could not unsee or ignore the dark twin of those capabilities. It was clear that safe scaling of AI biology needed new defensive infrastructure to contain and counter the emerging threats. We spun out Red Queen Bio to build it. This work has begun with a $15M seed round, led by OpenAI and joined by mission-aligned investo

Red Queen Bio + Red Queen Bio Media Work with us Contact red queen bio AI is accelerating and reshaping biology, drug development, and medicine, and the pace is picking up with more data and wider adoption. This increasing capacity for cures can also be used to do harm. As AI lowers the barriers to engineering dangerous pathogens, US biodefense faces a threat landscape that evolves faster than its legacy systems can adapt. The Red Queen hypothesis describes a species’ co-evolution with ever-evolving opponents. Our mission is to scale biological defenses faster than frontier AI capabilities gro

Explore this link on the map →

related reading